Stay updated on NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial
Sign up to get notified when there's something new on the NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial page.

Latest updates to the NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial page
- Check4 days agoChange DetectedThe Record History shows the addition of Revision v3.3.4 and the removal of Revision v3.3.3. These changes are metadata about the history log rather than core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page history shows an addition of revision v3.3.2 and removal of v3.2.0, which are administrative versioning updates with no impact on study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe Notice about lapse in government funding and operating status information was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check75 days agoChange DetectedThe new screenshot mirrors the old one, showing the same version history and study status sections with only visual/layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedMajor change: page now advertises a government operating-status notice and updates the release version to v3.2.0; previous v3.1.0 label was removed.SummaryDifference12%

Stay in the know with updates to NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NRX100 vs. Placebo in Suicidal Bipolar Depression Clinical Trial page.